spacer
home > ict > winter 2019 > automatic improvements
PUBLICATIONS
International Clinical Trials

Automatic Improvements

Despite the Industrial Internet of Things (IIoT) providing the means to automate inventory management processes, many healthcare facilities still rely on manual approaches. These usually take the form of databases, although some organisations still have not progressed past paper-based records. Regardless of the technique, manual inventory management is time-consuming and prone to errors. When Randall Lipps’ daughter required hospital treatment, he was shocked by the inefficiency of the hospital staff. This led to him founding Omnicell in 1992 so that hospitals could automate their inventory management processes, allowing clinicians to spend more time directly caring for patients.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Jonathan Wilkins is the Marketing Director at industrial automation components supplier, EU Automation. He is a professional brand advocate and commercial marketing strategist, focussing on delivering growth via a multichannel approach that has a significant positive impact on business. Jonathan has been part of the EU Automation team since its humble beginning nine years ago and has over a decade of experience in marketing.
spacer
Jonathan Wilkins
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Brooks Introduces Azenta Life Sciences To Advance Innovative Sample Solutions

CHELMSFORD, Mass., Sept. 28, 2021 -- Today Brooks Automation, Inc. (Nasdaq: BRKS) announces Brooks Life Sciences Services and Products businesses will be rebranded under the creation of a new identity – Azenta Life Sciences ("Azenta").
More info >>

White Papers

The Role of the CRO in Effective Risk-Based Monitoring

Medpace

The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement